ChronoScape

AI-Enhanced Virtual Environments for Clinical Exploration

INVESTMENT TERMS
Future Equity
$4M valuation cap

Highlights

1
Our core protocol achieves a 65.9% PTSD remission rate and reduces patient dropout to 2%.
2
We are building a proprietary AI engine that rapidly turns a memory into a 3D VR environment.
3
$1.3 Trillion tech convergence addresses a multibillion-dollar annual healthcare crisis.
4
Our AI agent uses real-time heart rate and eye-tracking data to quantify healing and ensure safety.

Team

Pitch Deck

1 / —

Healing Trauma When Words Aren’t Enough

For millions of veterans, first responders, and civilians, trauma doesn’t live in words—it lives in the nervous system. Yet most PTSD care still relies on talking about experiences that the body cannot safely revisit.

ChronoScape was built to change that.

We deliver Virtual Reality Exposure Therapy (VRET) using AI, immersive VR, and real-time biometrics to help patients confront and process trauma in a controlled, compassionate way. Clinicians simply describe what’s needed in natural language, and ChronoScape creates personalized therapeutic environments that adapt in real time to the patient’s physiology.

This approach works. Clinical evidence supporting VRET shows 65.9% remission rates and only 2% dropout, giving people a real path forward—not just symptom management.

We are starting where the need is greatest—veterans, first responders, and defense—but our mission extends to the broader $240B global mental-health market. ChronoScape is licensed to clinics and institutions that serve those who carry invisible wounds every day.

By investing in ChronoScape, you’re not just backing a healthcare technology platform. You’re helping build the infrastructure for a future where trauma treatment is effective, scalable, and humane.

Overview